21世纪经济报道记者申俊涵北京报道今年以来,国产创新药出海迎来大爆发。统计数据显示,2025年1-5月,中国创新药企对外授权(license-out)交易总金额已达455亿美元,而2024年全年的对外授权交易金额为519亿美元。尤其是5月20日,中国创新药行业迎来里程碑事件。三生制药与辉瑞达成最高超60亿美元的全球独家开发权协议,刷新了中国创新药License-out的首付款纪录(12.5亿美元)...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.